Cross-Effects in Folding and Phase Transitions of hnRNP A1 and C9Orf72 RNA G4 In Vitro
Molecules · 2024
DOI: 10.3390/molecules29184369 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Tatiana Vedekhina und 9 weiteren Autor:innen. Beteiligte Einrichtung: Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Malaya Pirogovskaya, 1a, 119435 Mos…. Hauptthemen laut MEDLINE: Heterogeneous Nuclear Ribonucleoprotein A1, G-Quadruplexes, C9orf72 Protein, Phase Transition. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation, The State Assignment, The Ministry of Science and Higher Education of the Russian Federation.
Abstract (Originalsprache)
Abnormal intracellular phase transitions in mutant hnRNP A1 may underlie the development of several neurodegenerative diseases. The risk of these diseases increases upon C9Orf72 repeat expansion and the accumulation of the corresponding G-quadruplex (G4)-forming RNA, but the link between this RNA and the disruption of hnRNP A1 homeostasis has not been fully explored so far. Our aim was to clarify the mutual effects of hnRNP A1 and C9Orf72 G4 in vitro. Using various optical methods and atomic force microscopy, we investigated the influence of the G4 on the formation of cross-beta fibrils by the mutant prion-like domain (PLD) of hnRNP A1 and on the co-separation of the non-mutant protein with a typical SR-rich fragment of a splicing factor (SRSF), which normally drives the assembly of nuclear speckles. The G4 was shown to act in a holdase-like manner, i.e., to restrict the fibrillation of the hnRNP A1 PLD, presumably through interactions with the PLD-flanking RGG motif. These interactions resulted in partial unwinding of the G4, suggesting a helicase-like activity of hnRNP A1 RGG. At the same time, the G4 was shown to disrupt hnRNP A1 co-separation with SRSF, suggesting its possible contribution to pathology through interference with splicing regulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Malaya Pirogovskaya, 1a, 119435 Moscow, Russia.
- Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Malaya Pirogovskaya, 1a, 11…
- Lomonosov Institute of Fine Chemical Technologies, MIREA-Russian Technological University, Vernadsky Avenue, 86, 119454 Moscow, Russia.
- A.P. Nelyubin Institute of Pharmacy, I.M. Sechenov First Moscow State Medical University of the Ministry of Healthcare of the Russian Federation (Sechenov University), Trubetskaya Str., 8-2, 119991 Moscow, Russia.
ORCID-Profile: Tatiana Vedekhina, Iuliia Pavlova, Pavel Rubtsov
Förderung
- Russian Science Foundation
- The State Assignment
- The Ministry of Science and Higher Education of the Russian Federation
- State Assignment
- Ministry of Science and Higher Education of the Russian Federation
Zitieren
APA
Vedekhina, T., Svetlova, J., Pavlova, I., Barinov, N., Alieva, S., Malakhova, E., Rubtsov, P., Shtork, A., Klinov, D., & Varizhuk, A. (2024). Cross-Effects in Folding and Phase Transitions of hnRNP A1 and C9Orf72 RNA G4 In Vitro. Molecules. https://doi.org/10.3390/molecules29184369
Vancouver
Vedekhina T, Svetlova J, Pavlova I, Barinov N, Alieva S, Malakhova E, et al. Cross-Effects in Folding and Phase Transitions of hnRNP A1 and C9Orf72 RNA G4 In Vitro. Molecules. 2024. doi:10.3390/molecules29184369
BibTeX
@article{Vedekhina2024,
author = {Vedekhina, Tatiana and Svetlova, Julia and Pavlova, Iuliia and Barinov, Nikolay and Alieva, Sabina and Malakhova, Elizaveta and Rubtsov, Pavel and Shtork, Alina and Klinov, Dmitry and Varizhuk, Anna},
title = {Cross-Effects in Folding and Phase Transitions of hnRNP A1 and C9Orf72 RNA G4 In Vitro},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29184369}
}
EUVIMED